Osteopore Ltd (ASX: OSX) Share Price and News

Mr Leong has corporate, management and directorship experience in a range of functions in a diverse range of industries having undertaken several C suite roles (CEO, COO, & CFO) in several private as well as listed companies. He Holds Directorships as Non Executive Director of MDR Limited (SGX:Y3D), Non Executive Director of HS Optimus Holdings Limited (SGX:504), Non Executive Director of 9R Limited (SGX:1Y1) Non Executive Director of LMIRT Management Ltd (SGX:D5IU), Non Executive Director of CytoMed Therapeutics Limited (NASDAQ: GDTC). He held directorships Non Executive Director of LCT Holdings Limited (SGX: delisted December 2020) Executive Director of LifeBrandz Ltd (SGX: 1D3).

Mr Teoh is currently the Founding Director and Distinguished Yule Chair Professor, Center for Advanced Medical Engineering (CAME) at the College of Materials Science and Engineering, Hunan University, China. He is Emeritus Professor at School of Chemical and Biomedical Engineering (SCBE) and held joint appointment with the Lee Kong Chian School of Medicine (LKC Med) at Nanyang Technological University (NTU). His contribution is in the development and clinical translation of 3D bioresorbable scaffolds. his research journey focused on translating the materials research to biomedical benefits. He is a Fellow of the Academy of Engineers Singapore and Chief Engineer at Skin Research Institute of Singapore. His research focused on the study of mechanisms that promote cells proliferation and differentiation as a result of mechano induction through load bearing scaffolds for tissue regeneration and remodelling. Presently, he focuses on regenerative medicine research from tissue engineering bone and skin to biomimetic bioreactors to fish collagen, decellularized organs and others. With more than 37 PhDs, 270 research publications and 22 patents and technical disclosures, he is a forerunner and excellent educator in bioengineering and research scientist in translational regenerative medicine.

Mr Ow has accumulated more than twenty years of international experience spanning various industries, such as infrastructure, resources, property, and fast moving consumer goods. Throughout his career, he has undertaken several finance and management positions within multinational corporations. Presently, Mr Ow holds the role of Chief Financial Officer at Greenpool Capital, a fully integrated property investment, asset, and development firm. In addition to his professional endeavors, he has also served as a Trustee Director on the Rio Tinto Staff Superannuation Fund, which has since merged with Equip Super.

Mr Keenan is a former Australian Government Cabinet Minister and brings invaluable expertise in public policy and corporate governance. He served as a Federal Member of Parliament from 2004 to 2019, holding senior ministry positions in the Abbott, Turnbull, and Morrison Governments between 2013 to 2019. His ministerial portfolios included Human Services, where he provided direction and oversight of Medicare, as well as Justice, Counter Terrorism, and Digital Transformation. Notably, Mr. Keenan also serves on the Board of U Group and Co, as well as the Australian Strategic Policy Institute.

-

-

-

-